Has the Catapult share price bottomed out?

The Catapult Group International Ltd (ASX: CAT) share price could be a long term buy.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

After hitting an all-time high of $4.29 in 2016, the Catapult Group International Ltd (ASX: CAT) share price has been in a steady decline. Recently there has been renewed interest in the sports analytics business, however. Following a rocky start to the year, the Catapult share price has doubled from its 2019 low of 60.5 cents. Improved earnings and a pipeline of products and deals could make the Catapult share price a long term buy.

What does Catapult do?

Catapult are world leaders in sports analytics and solutions, providing sports teams and athletes with technology that tracks and measures performance and recovery. In the modern age where data technology is of premium value, Catapult provides elite performers and teams with metrics and information they can use to tailor strategy, training and recovery regimes.

Catapult operates three divisions; elite video, wearables, and prosumer. Elite video tools allow teams and coaching staff to monitor and improve game strategy and training regimes. Wearables provide data for athlete performance which can be used to measure strength and conditioning. Prosumer is the division of Catapult which combines video and wearables allowing athletes to track key performance metrics and benchmark themselves against peers.

Currently, Catapult has more than 2500 elite clients, which include iconic brands of global sports such as soccer giants Chelsea Football Club, Real Madrid CF, Milwaukee Bucks in the NBA and numerous college football teams in the USA.

Mixed earnings

The Catapult business model involves selling access to video, wearables and prosumer divisions on a capital and subscription basis. Earlier this year Catapult proved that its financial performance was improving when it reported half-year earnings.

Catapult reported that the core elite business delivered high growth with annual recurring revenue (ARR) improving 25% to $57.4 million. Revenue for the half year was $43.0 million, a 32% increase from the previous year and customer churn was 3.5% for the period, down from 8.4% indicating renewed loyalty. EBITDA reported as a loss of $1.4 million, a 73% improvement from a $3.8 million loss they year prior and free cash flow was a negative $1.6 million.

New deals and products

Catapult plans to launch its next-generation wearable product 'Vector' in 2019. The new product aims to deliver new levels of accuracy and usability with additional tracking functionality and an embedded heart rate monitor. In addition, Catapult has ventured into the sub-elite market with the launch of PlayerTek+, a device that delivers similar metric measurement to its elite products, but at a lower price point.

In April Catapult announced an aggregated contract with the NRL for three seasons, establishing itself as a supplier of technology to all NRL clubs, NRLW teams, national representative teams and match officials. This follows renewed aggregate partnerships with the AFL, AFLW and NBL.

Foolish takeaway

In my opinion, Catapult is a fascinating company servicing a relatively niche market with huge growth potential. Instead of picking the bottom I would like to see Catapult's core business and recurring subscription revenue consistently grow. For this reason, I remain cautious and will be adding Catapult to my watchlist and waiting for the share price to consolidate before buying.

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Catapult Group International Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »